PHR NYSE Week ended 31 Jul 2026

Weekly Investor Report

Phreesia Inc · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 10.73 USD
5.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -3.0% below the Trend Line and sits at 11.8% of its 52-week range. The latest completed week returned 5.0%, after a -1.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 50/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 33d.

Setup score 28 out of 100
Latest Close 10.73 USD 31 Jul 2026
1W Return 5.0% latest completed week
4W Return -1.9% short-term follow-through
12W Return 5.5% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.0% Latest completed week; four-week move -1.9%. Indicator stack 5/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 50/100 conviction; expected move 13.0%. News sentiment 47/100 60 relevant articles in the latest sentiment read. Event risk 33d Next report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -3.0% below the Trend Line and sits at 11.8% of its 52-week range. The latest completed week returned 5.0%, after a -1.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1912-week average 0.08

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.9% over four weeks, 5.5% over 12 weeks, and -59.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W5.0%
4W-1.9%
12W5.5%
26W-20.1%
52W-59.3%
Active trend streak0 weeks
Active weeks in one year5
Trend breadth9.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.04Latest activity-pressure read.
Pressure change29.9%Four-week change in activity pressure.
Leadership-39.53Latest relative-leadership reading.
RS change8.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 94% Model confidence 94%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength11/100Blend of value, momentum, and quality. Underlying universe rank 90; rank 1 is best.
Value24/100Relative valuation strength. Underlying universe rank 77; rank 1 is best.
Quality65/100Profitability and accounting quality. Underlying universe rank 36; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
68.8x
Price divided by trailing earnings.
Price / sales
1.3x
Market value relative to trailing revenue.
EV / EBITDA
15.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
15.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
65.8%
Gross profit retained from each unit of revenue.
Operating margin
1.6%
Operating profit retained from revenue.
Free-cash-flow margin
20.8%
Free cash flow generated from revenue.
Return on invested capital
1.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
39.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

PHR shows volatility options pressure with a 50/100 conviction score, put-call volume ratio of 0.21, expected move of 13.0%, and Sharemaestro trend signal inactive.

Conviction50/100
Expected move13.0%
Put/call volume0.21
Pressure73
Speculation42
Volatility96
Trend agreement0
Open options detail
Insider activity11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment47/100

Weighted news tone is neutral across 60 relevant articles.

14 positive · 31 neutral · 15 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings33dNext report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
Options expected move13.0%Nearest-chain priced movement where available.
52-week drawdown-67.2%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+13.8%Week of 17 Apr.
Worst week-23.8%Week of 3 Apr.
Latest week+5.0%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains3
Flat weeks0
Modest losses7
Sharp losses7
Recent vol6.5%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -6.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.19; No reversal markers Factors25/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 66; Small Cap Core rank 72 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options35/100

PHR shows volatility options pressure with a 50/100 conviction score, put-call volume ratio of 0.21, expected move of 13.0%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 13.0% Sentiment47/100

Weighted news tone is neutral across 60 relevant articles.

PHR|Phreesia Inc|Price:10.725|Chg%:+0.115 Insiders11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings33d

Next report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202610.73 USD5.0%11.06 USD20.85 USD1.04-39.533.8MOff
24 Jul 202610.22 USD-4.6%11.25 USD20.97 USD1.02-43.083.3MOff
17 Jul 202610.71 USD-0.1%11.47 USD21.10 USD1.03-42.013.6MOff
10 Jul 202610.72 USD-2.0%11.67 USD21.23 USD0.94-44.003.7MOff
3 Jul 202610.94 USD8.6%11.85 USD21.38 USD0.80-43.334.3MOff
26 Jun 202610.07 USD7.4%12.16 USD21.49 USD0.70-47.957.5MOff
19 Jun 20269.38 USD3.5%12.51 USD21.63 USD0.68-53.775.0MOff
12 Jun 20269.06 USD-5.0%12.87 USD21.76 USD0.59-55.934.8MOff
5 Jun 20269.54 USD-3.2%13.29 USD21.91 USD0.52-54.348.2MOff
29 May 20269.86 USD10.5%13.71 USD22.06 USD0.44-54.9812.4MOff
22 May 20268.92 USD1.7%14.13 USD22.20 USD0.18-59.467.8MOff
15 May 20268.77 USD-13.8%14.62 USD22.34 USD-0.04-60.576.6MOff
8 May 202610.17 USD5.2%15.07 USD22.48 USD-0.32-55.085.6MOff
1 May 20269.67 USD1.4%15.47 USD22.60 USD-0.66-57.146.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.